- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
NephroGenex Inc+ Add to Watchlist
NRX:US4.8400 USD 0.0100 0.21%
As of 15:57:01 ET on 07/29/2014.
Company Profile for NephroGenex Inc (NRX)
NephroGenex, Inc. develops novel drugs for the treatment of kidney disease. The Company is developing a small molecule drug that acts as an inhibitor of the pathogenic oxidative chemistries which are elevated in diabetic patients.
Key Executives for NephroGenex Inc (NRX)
|Pierre LegaultChief Executive Officer||J Wesley FoxPres/Chief Scientific Officer|
|John P HamillCFO/Treasurer/Secretary||Bob PetersonVP:Product Dev|